Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
KUNLUN ENERGY
00135
CN Stock MarketDetailed Quotes
Jiangsu Kanion Pharmaceutical (600557)
- 12.49
- -0.25-1.96%
Trading May 20 14:46 CST
7.07BMarket Cap23.57P/E (TTM)
12.71High12.37Low61.02KlotVolume12.71Open12.74Prev Close76.14MTurnover1.08%Turnover Ratio23.26P/E (Static)566.16MShares20.2052wk High1.44P/B7.07BFloat Cap12.3752wk Low14.01Limit Up566.16MShs Float33.30Historical High11.47Limit Down2.67%Range %-0.53Historical Low--Dividend TTM12.48Avg Price40.12KlotAsk--Div Yield TTM100Lot Size20.43KlotBid
Jiangsu Kanion Pharmaceutical (600557) Cash Flow
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -3.23%922.47M | -20.44%3.82B | -24.72%2.71B | -34.92%1.72B | -31.09%953.25M | -14.98%4.8B | -14.34%3.6B | -9.23%2.65B | 9.29%1.38B | 12.29%5.64B |
| Cash received relating to other operating activities | -36.79%27.53M | 12.68%193.7M | -15.52%149.9M | -26.18%117.95M | -53.35%43.56M | 30.70%171.91M | 47.47%177.43M | 161.38%159.78M | 308.11%93.37M | 153.78%131.53M |
| Cash inflows from operating activities | -4.70%950M | -19.29%4.01B | -24.29%2.86B | -34.43%1.84B | -32.49%996.81M | -13.94%4.97B | -12.62%3.78B | -5.73%2.81B | 14.60%1.48B | 13.63%5.78B |
| Goods services cash paid | 2.69%156.28M | -35.08%660.97M | -48.24%468.86M | -54.13%283.36M | -58.81%152.19M | -12.40%1.02B | -2.05%905.86M | -9.06%617.77M | -4.03%369.51M | 17.15%1.16B |
| Staff behalf paid | 1.54%207.74M | -10.46%715.6M | -11.85%545.39M | -12.42%385.2M | -19.73%204.6M | 10.99%799.18M | 8.08%618.68M | 13.36%439.82M | 25.64%254.89M | 22.44%720.06M |
| All taxes paid | -1.98%108.98M | -21.16%328.51M | -32.87%231.77M | -52.74%154.04M | -41.62%111.19M | -27.84%416.7M | -18.69%345.26M | 6.79%325.92M | -6.71%190.47M | 11.73%577.46M |
| Cash paid relating to other operating activities | -9.03%411.09M | -16.62%1.7B | -5.35%1.27B | -17.16%874.84M | -3.83%451.9M | -13.22%2.03B | -17.74%1.34B | -8.22%1.06B | -15.66%469.88M | 17.76%2.34B |
| Cash outflows from operating activities | -3.89%884.1M | -20.31%3.4B | -21.65%2.52B | -30.42%1.7B | -28.40%919.88M | -11.15%4.27B | -9.61%3.21B | -3.31%2.44B | -4.78%1.28B | 17.52%4.8B |
| Net cash flows from operating activities | -14.35%65.9M | -13.08%610.59M | -39.17%346.12M | -60.91%144.35M | -59.90%76.94M | -27.75%702.49M | -26.45%569.04M | -19.09%369.23M | 416.26%191.88M | -2.37%972.32M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -96.94%6.97M | -70.77%599.24M | -68.55%489.01M | -68.96%388.01M | -54.10%228.01M | 94.81%2.05B | 253.50%1.56B | 818.51%1.25B | 606.88%496.77M | 14.25%1.05B |
| Cash received from returns on investments | 223.40%2.64M | -54.51%10.26M | -58.68%4.92M | -37.33%4.87M | -89.37%817.66K | 52.48%22.56M | 80.91%11.92M | 752.42%7.77M | 1,617.63%7.69M | 255.90%14.8M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 2,307.33%153.51K | -77.78%2.04M | -78.54%1.95M | -98.02%179.71K | -93.29%6.38K | 343.87%9.18M | 2,107.45%9.1M | 3,175.31%9.08M | -54.47%94.99K | -90.56%2.07M |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | --10.25M | --10.25M | --10.25M | --10.25M | ---- |
| Cash inflows from investing activities | -95.73%9.76M | -70.77%611.55M | -68.74%495.89M | -69.22%393.06M | -55.55%228.84M | 95.66%2.09B | 254.96%1.59B | 830.30%1.28B | 625.77%514.82M | 12.88%1.07B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 94.34%187.66M | 9.46%521.78M | 7.73%335.66M | -10.52%206.73M | -21.70%96.56M | 53.13%476.69M | 29.94%311.56M | 177.47%231.04M | 181.08%123.32M | 47.47%311.29M |
| Cash paid to acquire investments | ---- | -62.97%603.6M | -69.34%493.6M | -58.64%413.6M | -43.43%282.83M | 24.17%1.63B | 68.23%1.61B | 657.58%1B | 443.48%500M | 45.86%1.31B |
| Cash outflows from investing activities | -50.54%187.66M | -46.58%1.13B | -56.84%829.26M | -49.61%620.33M | -39.13%379.39M | 29.72%2.11B | 60.56%1.92B | 471.87%1.23B | 358.75%623.32M | 46.17%1.62B |
| Net cash flows from investing activities | -18.16%-177.89M | -3,397.33%-513.83M | 0.57%-333.37M | -593.36%-227.27M | -38.75%-150.55M | 97.35%-14.69M | 55.29%-335.29M | 159.07%46.06M | -67.08%-108.5M | -238.46%-554.88M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -92.93%4.86M |
| Cash received relating to other financing activities | ---- | ---- | ---- | ---- | ---- | -50.11%40.67M | --36.33M | --18.66M | ---- | --81.53M |
| Cash inflows from financing activities | ---- | ---- | ---- | ---- | ---- | -52.92%40.67M | --36.33M | --18.66M | ---- | 25.75%86.39M |
| Dividend interest payment | ---- | -57.90%91.9M | ---- | ---- | ---- | 66.81%218.3M | 68.56%220.76M | 9,163.64%218.4M | 0.00%2.36M | 5,160.43%130.87M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | ---- | ---- | ---- | 100.00%4.72M | --4.72M | --2.36M | ---- | --2.36M |
| Cash payments relating to other financing activities | ---- | -92.45%24.49M | -88.90%23.15M | -80.45%23.17M | ---- | 8,426.91%324.5M | --208.63M | --118.54M | --14.12M | --3.81M |
| Cash outflows from financing activities | ---- | -78.56%116.39M | -94.61%23.15M | -93.12%23.17M | ---- | 303.05%542.8M | 227.86%429.4M | 14,191.57%336.94M | 598.98%16.48M | -43.17%134.67M |
| Net cash flows from financing activities | ---- | 76.82%-116.39M | 94.11%-23.15M | 92.72%-23.17M | ---- | -939.91%-502.12M | -200.12%-393.07M | -13,400.29%-318.29M | -598.98%-16.48M | 71.31%-48.29M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -2,018.77%-140.56K | -127.17%-40K | -106.10%-8.22K | -101.68%-2K | --7.33K | 138.32%147.22K | --134.71K | --119.25K | ---- | -59.13%61.77K |
| Net increase in cash and cash equivalents | -52.34%-112.14M | -110.59%-19.67M | 93.46%-10.4M | -209.23%-106.09M | -210.03%-73.61M | -49.67%185.82M | -48.58%-159.18M | -74.17%97.13M | 152.28%66.9M | -44.38%369.21M |
| Add:Begin period cash and cash equivalents | -0.91%2.15B | 9.38%2.17B | 9.38%2.17B | 9.38%2.17B | 9.38%2.17B | 22.89%1.98B | 23.77%1.98B | 23.77%1.98B | 23.77%1.98B | 72.04%1.61B |
| End period cash equivalent | -2.78%2.04B | -0.91%2.15B | 18.36%2.16B | -0.84%2.06B | 2.21%2.09B | 9.38%2.17B | 21.99%1.82B | 5.15%2.08B | 39.06%2.05B | 23.77%1.98B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On May 19, Eastern Time, Trump issued a clear countdown: 'in two or three days—maybe Friday, Saturday, Sunday, or early next week'—the U.S.
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm